ALLMedicine™ Immunoglobulin Deficiency Center

Feb 23rd, 2023 - Demographic and socioeconomic factors are recognized to contribute to disparities in healthcare outcomes. Originally, bronchiectasis was described in a population of predominantly White ethnic group of patients in which racial disparity could not ...

Oct 21st, 2022 - Primary Ig deficiencies are a heterogeneous group of disorders with widespread implications for the unified airway. Manifestations can vary greatly, with some patients being asymptomatic, whereas others suffering from acute and chronic life-threat...

Sep 27th, 2022 - Multiple sclerosis (MS) is the most common cause of mental and physical disability in young adults affecting approximately 10'000-15'000 persons in Switzerland (incidence 16/100000; prevalence 190/100000). MS-fatigue affects at least 75% of the MS...

Nov 9th, 2021 - Mast cell activation disease (MCAD) includes single organ disease such as asthma, urticaria, and gastroenteritis, as well as multiorgan system involvement such as mast cell activation syndrome and anaphylaxis. Reports link MCAD with hypermobile Eh...

Apr 12th, 2021 - Type 1 diabetes (T1D) may coexist with primary immunodeficiencies, indicating a shared genetic background. To evaluate the prevalence and clinical characteristics of immunoglobulin deficiency (IgD) among children with T1D. Serum samples and medica...

Sep 27th, 2022 - Multiple sclerosis (MS) is the most common cause of mental and physical disability in young adults affecting approximately 10'000-15'000 persons in Switzerland (incidence 16/100000; prevalence 190/100000). MS-fatigue affects at least 75% of the MS...

Sep 23rd, 2013 - OBJECTIVES: Primary To test the feasibility and safety of infusing anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells (CD20Bi-AATC) before stem cell mobilization and collection for autologous peripheral blood stem cell transplantatio...

Mar 16th, 2010 - Ataxia-telangiectasia (AT) is a rare progressive neurodegenerative autosomal recessive disorder characterized by cerebellar ataxia, neuromotor dysfunction, oculocutaneous telangiectasia and immunodeficiency. AT patients are vulnerable to cancer an...

Jul 8th, 2022 - Immunocompromised individuals made up 12.2% of all COVID-related hospitalizations, despite accounting for only about 3% of the U.S. population, a CDC report showed. And once hospitalized, there was no difference in the risk for death between vacci...

Apr 12th, 2022 - CoVac-1, a multi-peptide COVID-19 vaccine, elicited promising T-cell activity and safety in patients with cancer who have disease- or treatment-related immunoglobulin deficiency, according to findings from the phase 1/2 CoVac-1 trial (NCT04954469)...

Sep 9th, 2021 - Patients with chronic lymphocytic leukemia (CLL) are at an increased risk for infection whether they are in the premalignant state of monoclonal B lymphocytosis (MBL), during active surveillance for those are treatment naïve, or are on active trea...

May 29th, 2020 - Phlegmonous gastritis The patient was treated with intravenous antibiotics (amoxicillin/clavulanic acid 6. 6 g/d) and a proton pump inhibitor (esomeprazole 80 mg/d).

Management The first step in managing difficult-to-treat asthma is to confirm the diagnosis of asthma.[6,7] This typically includes spirometry before and after bronchodilation to seek objective evidence of reversible airway obstruction. If baselin...